To determine the expression of components in Toll-like receptors (TLRs)/Nod-like receptors (NLRs)/inflammasome/caspase-1/interleukin (IL-1)-β pathway, we examined the expression profiles of those genes by analyzing the data from expression sequence tag cDNA cloning and sequencing. We made several important findings: firstly, among 11 tissues examined, vascular tissues and heart express fewer types of TLRs and NLRs than immune and defense tissues including blood, lymph nodes, thymus and trachea; secondly, brain, lymph nodes and thymus do not express proinflammatory cytokines IL-1β and IL-18 constitutively, suggesting that these two cytokines need to be upregulated in the tissues; and thirdly, based on the expression data of three characterized inflammasomes (NALP1, NALP3 and IPAF inflammasome), the examined tissues can be classified into three tiers: the first tier tissues including brain, placenta, blood and thymus express inflammasome(s) in constitutive status; the second tier tissues have inflammasome(s) in nearly-ready expression status (with the requirement of upregulation of one component); the third tier tissues, like heart and bone marrow, require upregulation of at least two components in order to assemble functional inflammasomes. Our original model of three-tier expression of inflammasomes would suggest a new concept of tissue inflammation privilege, and provides an insight to the differences among tissues in initiating acute inflammation in response to stimuli.
WangHJiangXYangF. Hyperhomocysteinemia accelerates atherosclerosis in cystathionine beta-synthase and apolipoprotein E double knock-out mice with and without dietary perturbation. Blood2003; 101:3901–3907.
4.
JiangXYangFTanH. Hyperhomocystinemia impairs endothelial function and eNOS activity via PKC activation. Arterioscler Thromb Vasc Biol2005; 25:2515–2521.
5.
TanHJiangXYangF. Hyperhomocysteinemia inhibits post-injury reendothelialization in mice. Cardiovasc Res. 2006;69:253–262.
6.
LiaoDTanHHuiR. Hyperhomocysteinemia decreases circulating high-density lipoprotein by inhibiting apolipoprotein A-1 Protein synthesis and enhancing HDL cholesterol clearance. Circ Res. 2006;99:598–606.
7.
JamaluddinMDChenIYangF. Homocysteine inhibits endothelial cell growth via DNA hypomethylation of the cyclin Agene. Blood. 2007;110:3648–3655.
8.
YanYChenYYangF. HLA-A2.1-restricted T cells react to SEREX-defined tumor antigen CML66L and are suppressed by CD4+CD25+ regulatory T cells. Int J Immunopathol Pharmacol2007;20:75–89.
9.
YangXF. Factors regulating apoptosis and homeostasis of CD4+CD25highFOXP3+ regulatory T cells are new therapeutic targets. Front Biosci. 2008;13:1472–1499.
10.
XiongZSongJYanY. Higher expression of Bax in regulatory T cells increases vascular inflammation. Front Biosci2008; 13:7143–7155.
11.
XiongZYanYSongJ. Expression of TCTP antisense in CD25(high) regulatory T cells aggravates cuff-injured vascular inflammation. Atherosclerosis. 2009;203:401–408.
12.
StollLLDenningGMWeintraubNL. Potential role of endotoxin as a proinflammatory mediator of atherosclerosis. Arterioscler Thromb Vasc Biol. 2004;24:2227–2236.
13.
TobiasPSCurtissLK. Toll-like receptors in atherosclerosis. Biochem Soc Trans. 2007;35:1453–1455.
14.
MullickAETobiasPSCurtissLK. Modulation of atherosclerosis in mice by Toll-like receptor 2. J Clin Invest. 2005;115:3149–3156.
15.
MichelsenKSWongMHShahPK. Lack of Toll-like receptor 4 or myeloid differentiation factor 88 reduces atherosclerosis and alters plaque phenotype in mice deficient in apolipoprotein E. Proc Natl Acad Sci USA. 2004;101:10679–10684.
16.
TschoppJMartinonFBurnsK. NALPs: A novel protein family involved in inflammation. Nat Rev Mol Cell Biol. 2003;4:95–104.
17.
MartinonFBurnsKTschoppJ. The inflammasome: A molecular platform triggering activation of inflammatory caspases and processing of proIL-beta. Mol Cell. 2002;10:417–426.
18.
MatsudaNYamazakiHTakanoK. Priming by lipopolysaccharide exaggerates acute lung injury and mortality in responses to peptidoglycan through up-regulation of Toll-like receptor-2 expression in mice. Biochem Pharmacol. 2008;75:1065–1075.
19.
NgBYangFHustonDP. Increased noncanonical splicing of autoantigen transcripts provides the structural basis for expression of untolerized epitopes. J Allergy Clin Immunol. 2004;114:1463–1470.
20.
MartinsR PiresLeachREKrawetzSA. Whole-body gene expression by data mining. Genomics. 2001;72:34–42.
21.
ViemannDGoebelerMSchmidS. TNF induces distinct gene expression programs in microvascular and macrovascular human endothelial cells. J Leukoc Biol. 2006;80:174–185.
22.
EdfeldtKSwedenborgJHanssonGK. Expression of toll-like receptors in human atherosclerotic lesions: A possible pathway for plaque activation. Circulation. 2002;105:1158–1161.
23.
KummerJABroekhuizenREverettH. Inflammasome components NALP 1 and 3 show distinct but separate expression profiles in human tissues suggesting a site-specific role in the inflammatory response. J Histochem Cytochem. 2007;55:443–452.
24.
MartinonFTschoppJ. Inflammatory caspases and inflammasomes: Master switches of inflammation. Cell Death Differ. 2007;14:10–22.
25.
YanZQHanssonGK. Innate immunity, macrophage activation, and atherosclerosis. Immunol Rev. 2007;219:187–203.
26.
OpitzBHippenstielSEitelJ. Extra- and intracellular innate immune recognition in endothelial cells. Thromb Haemost. 2007;98:319–326.
27.
MasumotoJTaniguchiSAyukawaK. ASC, a novel 22-kDa protein, aggregates during apoptosis of human promyelocytic leukemia HL-60 cells. J Biol Chem. 1999;274:33835–33838.
PoyetJLSrinivasulaSMTnaniM. Identification of Ipaf, a human caspase-1-activating protein related to Apaf-1. J Biol Chem. 2001;276:28309–28313.
31.
YangX-FYinYingWangHong. Vascular inflammation and atherosclerosis are activated via receptors for PAMPs and suppressed by regulatory T cells. Drug Discovery Today Therapeutic Strategies. 2008; 5:125–142.
32.
IshikawaYSatohMItohT. Local expression of Toll-like receptor 4 at the site of ruptured plaques in patients with acute myocardial infarction. Clin Sci (Lond). 2008;115:133–140.
33.
ShuangCWongMHSchulteDJ. Differential expression of Toll-like receptor 2 (TLR2) and responses to TLR2 ligands between human and murine vascular endothelial cells. Journal of endotoxin research. 2007;13:281–296.
34.
ShioharaMTaniguchiSMasumotoJ. ASC, which is composed of a PYD and a CARD, is upregulated by inflammation and apoptosis in human neutrophils. Biochem Biophys Res Commun. 2002;293:1314–1318.
35.
VermaDLermMJulinderR Blomgran. Gene polymorphisms in the NALP3 inflammasome are associated with interleukin-1 production and severe inflammation: Relation to common inflammatory diseases?Arthritis Rheum. 2008;58:888–894.
36.
ThomSRFisherDXuYA. Adaptive responses and apoptosis in endothelial cells exposed to carbon monoxide. Proc Natl Acad Sci USA. 2000;97:1305–1310.
37.
GuptaSRadhaVFurukawaY. Direct transcriptional activation of human caspase-1 by tumor suppressor p53. J Biol Chem. 2001;276:10585–10588.
38.
YangFYangXF. New concepts in tumor antigens: Their significance in future immunotherapies for tumors. Cell Mol Immunol. 2005;2:331–341.
39.
StreileinJWStein-StreileinJ. Does innate immune privilege exist?J Leukoc Biol. 2000;67:479–487.
